Impact of FDG PET/CT in directing management of well differentiated neuroendocrine tumours with Ki67 <5%

被引：0
|
作者：
Agrawal, A. [1 ]
Choudhary, S. [1 ]
Puranik, A. [1 ]
Rangarajan, V. [1 ]
Shrikhande, S. [1 ]
Bal, M. [1 ]
Choudhary, V. [1 ]
Bhandare, M. [1 ]
Ramaswamy, A. [1 ]
Purandare, N. [1 ]
Shah, S. [1 ]
机构：
[1] Tata Mem Hosp, Mumbai, Maharashtra, India
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0353
引用
收藏
页码：S544 / S544
页数：1
相关论文
共 50 条
  • [11] Grading of Well-differentiated Pancreatic Neuroendocrine Tumors Is Improved by the Inclusion of Both Ki67 Proliferative Index and Mitotic Rate
    McCall, Chad M.
    Shi, Chanjuan
    Cornish, Toby C.
    Klimstra, David S.
    Tang, Laura H.
    Basturk, Olca
    Mun, Liew Jun
    Ellison, Trevor A.
    Wolfgang, Christopher L.
    Choti, Michael A.
    Schulick, Richard D.
    Edil, Barish H.
    Hruban, Ralph H.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (11) : 1671 - 1677
  • [12] Ki67 as a Prognostic Marker in Neuroendocrine Tumours: A Systematic Review of the Literature and Quantitative Synthesis of 5 Year Survival Data
    Richards-Taylor, S.
    Tilley, C.
    Hu, J. H.
    Pearce, N.
    Armstrong, T.
    Jaynes, E.
    Nolan, L.
    Cave, J.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 96 - 96
  • [13] Lesion-by-lesion correlation between uptake at FDG PET and the Ki67 proliferation index in resected pancreatic neuroendocrine tumors
    de Mestier, Louis
    Armani, Margot
    Cros, Jerome
    Hentic, Olivia
    Rebours, Vinciane
    Cadiot, Guillaume
    Sauvanet, Alain
    Couvelard, Anne
    Lebtahi, Rachida
    Ruszniewski, Philippe
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (12) : 1720 - 1724
  • [14] Diagnosis of Well-Differentiated Endocrine Carcinomas with High Ki-67 (≥10%): FDG-PET or SRS?
    Abgral, R.
    Leboulleux, S.
    Deandreis, D.
    Auperin, A.
    Dromain, C.
    Lumbroso, J.
    Schlumberger, M.
    Ducreux, M.
    Baudin, E.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 93 - 93
  • [15] Correlation of 18F-FDG uptake on PET/CT with Ki67 immunohistochemistry in pretreatment epithelial ovarian cancer
    Mayoral, M.
    Paredes, P.
    Saco, A.
    Fernandez-Martinez, A.
    Perlaza, P.
    Tapias, A.
    Fuste, P.
    Sebastia, M. C.
    Ordi, J.
    Pavia, J.
    Pahisa, J.
    Lomena, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S289 - S289
  • [16] The Effect of Tumor Heterogeneity on the Prognostic Value of Ki67 Labeling Index in Well-Differentiated Neuroendocrine Tumors (NETs) Metastatic to the Liver
    Yang, Z.
    Tang, L. H.
    Klimstra, D. S.
    MODERN PATHOLOGY, 2010, 23 : 375A - 375A
  • [17] MCM7 Expression Correlates With Tumor Size and Ki67 Index in Well-Differentiated Small Intestinal Neuroendocrine Tumors
    Zhou, Zhongren
    Numbere, Numbereye
    Huber, Aaron
    Shi, Chanjuan
    Gonzalez, Raul S.
    LABORATORY INVESTIGATION, 2018, 98 : 318 - 318
  • [18] MCM7 Expression Correlates With Tumor Size and Ki67 Index in Well-Differentiated Small Intestinal Neuroendocrine Tumors
    Zhou, Zhongren
    Numbere, Numbereye
    Huber, Aaron
    Shi, Chanjuan
    Gonzalez, Raul S.
    MODERN PATHOLOGY, 2018, 31 : 318 - 318
  • [19] The Effect of Tumor Heterogeneity on the Prognostic Value of Ki67 Labeling Index in Well-Differentiated Neuroendocrine Tumors (NETs) Metastatic to the Liver
    Yang, Z.
    Tang, L. H.
    Klimstra, D. S.
    LABORATORY INVESTIGATION, 2010, 90 : 375A - 375A
  • [20] Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumours: Comparison with the expression of the Ki-67 antigen
    Adams, S
    Baum, RP
    Hertel, A
    Schumm-Drager, PM
    Usadel, KH
    Hor, G
    NUCLEAR MEDICINE COMMUNICATIONS, 1998, 19 (07) : 641 - 647
12345